US Broker Ratings

Bioventus Inc. (BVS)

⚠️ No article content returned.

..

Prothena Corporation (PRTA) Stock Analysis: Exploring a 140% Upside Potential Amidst Clinical Innovations

Investors with an eye on the biotechnology sector might find Prothena Corporation plc (NASDAQ: PRTA) an intriguing prospect, especially given its considerable upside potential. This Ireland-based..

Definitive Healthcare Corp. (DH) Stock Analysis: Exploring a 69.64% Upside Potential

Definitive Healthcare Corp. (NASDAQ: DH), a leader in the health information services industry, presents a fascinating case for investors seeking opportunities in the healthcare sector. Headquartered..

Zymeworks Inc. (ZYME) Investor Outlook: A 44.55% Potential Upside Amidst Biotech Volatility

Zymeworks Inc. (NASDAQ: ZYME), a promising player in the biotechnology sector, is currently capturing investor attention with a significant potential upside of 44.55%. Trading at $28.71,..

Dianthus Therapeutics (DNTH): Analyst Consensus Predicts 68% Upside Potential for Biotech Innovator

Dianthus Therapeutics, Inc. (NASDAQ: DNTH), a dynamic player in the biotechnology sector, has caught the attention of investors with its ambitious pipeline targeting severe autoimmune diseases...

LENZ Therapeutics, Inc. (LENZ) Stock Analysis: A Biotech Contender with 473% Potential Upside

For investors with an appetite for high-risk, high-reward opportunities, LENZ Therapeutics, Inc. (NASDAQ: LENZ) is a biotechnology company that warrants attention. Based in Solana Beach, California,..

uniQure N.V. (QURE) Stock Analysis: Exploring a 138.60% Potential Upside in the Biotech Arena

uniQure N.V. (NASDAQ: QURE), a pioneering force in the biotechnology sector, is making waves with its ambitious gene therapy treatments targeting rare and severe diseases. With..

REGENXBIO Inc. (RGNX) Stock Analysis: Unpacking a Potential 218% Upside in the Biotech Sector

REGENXBIO Inc. (NASDAQ: RGNX), a pioneering biotechnology company based in Rockville, Maryland, is making waves with its innovative approach to gene therapy. The company’s focus on..

Neuropace, Inc. (NPCE) Stock Analysis: A 53.73% Potential Upside in the Medical Device Sector

Investors looking to tap into the burgeoning medical device sector might find Neuropace, Inc. (NASDAQ: NPCE) a compelling option. This Mountain View, California-based company is setting..

Ginkgo Bioworks Holdings (DNA) Investor Outlook: Challenges and Opportunities Amidst Market Volatility

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) continues to be a fascinating player in the biotechnology sector, offering innovative solutions in cell engineering and biosecurity. Despite its..

Organogenesis Holdings Inc. (ORGO) Stock Analysis: Is a 144% Upside Within Reach?

Investors seeking unique opportunities in the healthcare sector might consider taking a closer look at Organogenesis Holdings Inc. (NASDAQ: ORGO). Despite the current challenges, the company..

CeriBell, Inc. (CBLL) Stock Analysis: Riding High on Strong Revenue Growth and Bullish Analyst Ratings

CeriBell, Inc. (NASDAQ: CBLL), a healthcare pioneer in the medical devices sector, has been capturing the attention of investors with its innovative approach to EEG technology...

Savara, Inc. (SVRA) Stock Analysis: An Unveiling of Its 123% Potential Upside

Savara, Inc. (SVRA), a pivotal player in the biopharmaceutical landscape, is drawing significant investor attention with a potential upside that could redefine its market positioning. With..

Fortrea Holdings Inc. (FTRE) Stock Analysis: Navigating Investment Terrain with a 20.15 Forward P/E

Fortrea Holdings Inc. (NASDAQ: FTRE) is making a name for itself in the healthcare sector, specifically within the biotechnology industry. This contract research organization, based in..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Navigating a 44.53% Potential Upside in the Healthcare Sector

Sonida Senior Living, Inc. (SNDA), a prominent player in the healthcare sector under the medical care facilities industry, is capturing investor attention with a notable potential..

Capricor Therapeutics, Inc. (CAPR) Stock Analysis: Exploring a 307% Potential Upside in Biotechnology

Capricor Therapeutics, Inc. (NASDAQ: CAPR), a clinical-stage biotechnology company headquartered in San Diego, California, is drawing significant investor attention with its ambitious pipeline and substantial projected..

Simulations Plus, Inc. (SLP) Stock Analysis: A Steady Player in Health Information Services with 7.5% Revenue Growth

Simulations Plus, Inc. (NASDAQ: SLP) stands as a unique entity in the healthcare sector, specializing in health information services. Headquartered in the United States, Simulations Plus..

Precigen, Inc. (PGEN) Stock Analysis: Exploring a 105% Potential Upside in Biotech Innovation

Precigen, Inc. (NASDAQ: PGEN), a pioneering biopharmaceutical firm, stands out with its remarkable 105.57% potential upside, intriguing investors eager to capitalize on the biotech sector’s growth...

LifeMD, Inc. (LFMD) Stock Analysis: Eyeing a 250% Potential Upside Amid Strong Buy Ratings

LifeMD, Inc. (LFMD), a trailblazer in the burgeoning telehealth sector, is catching the attention of investors with a compelling potential upside of 250.22%. Despite facing challenges,..

InnovAge Holding Corp. (INNV) Stock Analysis: Exploring a Potential 29.87% Upside in the Healthcare Sector

InnovAge Holding Corp. (NASDAQ: INNV), a key player in the healthcare sector, offers investors a unique opportunity to tap into the burgeoning market of senior care..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds